Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 10
2019 10
2020 7
2021 7
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction.
Perrucci E, Marcantonini M, Arena E, Fulcheri C, Reggioli V, Dipilato AC, Palumbo I, Saldi S, Falcinelli L, Ingrosso G, Bini V, Aristei C. Perrucci E, et al. Among authors: saldi s. Rep Pract Oncol Radiother. 2023 Apr 6;28(1):1-8. doi: 10.5603/RPOR.a2023.0014. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 37122911 Free PMC article.
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription.
Cellini F, Di Rito A, Siepe G, Pastore F, Lattanzi E, Meaglia I, Tozzi A, Manfrida S, Longo S, Saldi S, Cassese R, Arcidiacono F, Fiore M, Masiello V, Mazzarella C, Diroma A, Miccichè F, Maurizi F, Dominici L, Scorsetti M, Santarelli M, Fusco V, Aristei C, Deodato F, Gambacorta MA, Maranzano E, Muto P, Valentini V, Morganti AG, Marino L, Donati CM, Di Franco R. Cellini F, et al. Among authors: saldi s. Adv Radiat Oncol. 2022 Nov 28;8(2):101134. doi: 10.1016/j.adro.2022.101134. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36632087 Free PMC article.
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Saldi S, Fulcheri CPL, Zucchetti C, Abdelhamid AMH, Carotti A, Pierini A, Ruggeri L, Tricarico S, Chiodi M, Ingrosso G, Bini V, Velardi A, Martelli MF, Hui SK, Aristei C. Saldi S, et al. Front Oncol. 2022 Dec 8;12:1035375. doi: 10.3389/fonc.2022.1035375. eCollection 2022. Front Oncol. 2022. PMID: 36568236 Free PMC article.
Feasibility of a Novel Sparse Orthogonal Collimator-Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality.
Abdelhamid AMH, Jiang L, Zuro D, Liu A, Madabushi SS, Ghimire H, Wong JYC, Saldi S, Fulcheri C, Zucchetti C, Pierini A, Sheng K, Aristei C, Hui SK. Abdelhamid AMH, et al. Among authors: saldi s. Front Oncol. 2022 Jul 18;12:941814. doi: 10.3389/fonc.2022.941814. eCollection 2022. Front Oncol. 2022. PMID: 35924145 Free PMC article.
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement.
Saldi S, Perriello VM, Falini L, Ruggeri L, Fulcheri C, Ciardelli S, Innocente A, Ballanti S, Baffa N, Flenghi L, Pierini A, Aristei C, Falini B. Saldi S, et al. Front Immunol. 2022 Jul 14;13:934700. doi: 10.3389/fimmu.2022.934700. eCollection 2022. Front Immunol. 2022. PMID: 35911683 Free PMC article.
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis.
Falini L, Venanzi A, Tini V, Innocente A, Ballanti S, Saldi S, Sivolella S, Pierini A, Aristei C, Tiacci E, Perriello VM, Falini B. Falini L, et al. Among authors: saldi s. Haematologica. 2023 Jan 1;108(1):290-294. doi: 10.3324/haematol.2022.281351. Haematologica. 2023. PMID: 35899391 Free PMC article. No abstract available.
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.
Valeriani M, Detti B, Fodor A, Caini S, Borghesi S, Trippa F, Triggiani L, Bruni A, Russo D, Saldi S, Di Staso M, Francolini G, Lancia A, Marinelli L, Di Muzio N, Aristei C, Livi L, Magrini SM, Ingrosso G. Valeriani M, et al. Among authors: saldi s. Radiol Med. 2022 Jan;127(1):108-116. doi: 10.1007/s11547-021-01424-x. Epub 2021 Nov 8. Radiol Med. 2022. PMID: 34748151
36 results